Israeli scientist says COVID-19 could be treated for under $1/day

Israeli scientist says COVID-19 could be treated for under $1/day

Double-blind study shows ivermectin reduces disease’s duration, infectiousness

Share to GabPrint

(JERUSALEM POST) – Ivermectin, a drug used to fight parasites in third-world countries, could help reduce the length of infection for people who contract coronavirus for less than a $1 a day, according to recent research by Sheba Medical Center in Tel Hashomer.

Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.

Ivermectin has been approved by the US Food and Drug Administration since 1987. The drug’s discoverers were awarded the 2015 Nobel Prize in medicine for its treatment of onchocerciasis, a disease caused by infection with a parasitic roundworm.


Comments

Popular posts from this blog

Top 7 MOST SURPRISING ways disease gets bred and spread since the pandemic began

New side effects from Pfizer and Moderna vaccines include kidney inflammation, renal disorders and skin reactions

Clot shot warning: Here’s what a blood clot looks like when LIQUID blood turns into a semi-solid gelatinous mass inside your body